Is SCLC up or down today?
SCLC is down 1.12% today, last at 31.01. This stock moved -1.12% versus the prior close.
SCLC · SCLC
SCLC (SCLC) is trading at 31.01, down 1.12% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 2 headlines skew mostly positive. Earnings stories led the conversation.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
SCLC is down 1.12% today, last at 31.01. This stock moved -1.12% versus the prior close.
Over the past 7 days, 2 headlines skew mostly positive. Earnings stories led the conversation. Dominant story: PHM: Recurring revenue up 18% YoY, net profit falls, ZepzelcaⓇ approved for first-line ES-SCLC - tradingview.com (1 source, bearish) RSI unavailable Price sits at 50% of its 52-week range Social (demo): 39% of recent mentions lean bullish — social mood is cautious.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: SCLC
27/ 100 index
-70.7% vs start of window
Based on 10,745 mentions over 30d
PHM: Recurring revenue up 18% YoY, net profit falls, ZepzelcaⓇ approved for first-line ES-SCLC - tradingview.com
Thoracic Radiotherapy Added to Atezolizumab Raises Fatal Toxicity Risk in ES-SCLC - Pharmacy Times
Adding Thoracic Radiotherapy to Chemo-Immunotherapy Fails in SCLC - Targeted Oncology
Immunochemotherapy Confirmed as First-Line Standard for Some SCLC - Oncology News Central
Review Outlines Rare, Complicated Cases of Co-Occurring SCLC and GI Cancers - The American Journal of Managed Care